Syncom Formulation (India) (BOM:524470) Marketable Securities : ₹0 Mil (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Syncom Formulation (India) Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Syncom Formulation (India)'s Marketable Securities for the quarter that ended in Dec. 2023 was ₹0 Mil.

Syncom Formulation (India)'s annual Marketable Securities declined from Mar. 2021 (₹713 Mil) to Mar. 2022 (₹400 Mil) but then increased from Mar. 2022 (₹400 Mil) to Mar. 2023 (₹700 Mil).

Syncom Formulation (India) Marketable Securities Historical Data

The historical data trend for Syncom Formulation (India)'s Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syncom Formulation (India) Marketable Securities Chart

Syncom Formulation (India) Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Marketable Securities

Get a 7-Day Free Trial

5.11

3.62

713.42

400.31

700.17

Syncom Formulation (India) Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Marketable Securities	Get a 7-Day Free Trial															-	700.17	-	612.17	-

Syncom Formulation (India) Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Syncom Formulation (India) (BOM:524470) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Syncom Formulation (India) Marketable Securities Related Terms

Thank you for viewing the detailed overview of Syncom Formulation (India)'s Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Syncom Formulation (India) (BOM:524470) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Syncom Formulation (India) Ltd (BOM:524470) » Definitions » Marketable Securities

Traded in Other Exchanges

SYNCOMF:India

Address

207, Saket Nagar, Near Saket Club, Indore, MP, IND, 452018

Website

https://www.sfil.in

Syncom Formulation (India) Ltd is in the business of pharmaceuticals. The company operates through three segments including manufacturing and dealings in Pharmaceutical drugs and formulations, Trading of commodities, and Renting of property. It manufactures and markets pharmaceutical formulation products in various dosage forms like tablets, capsules, liquids orals, liquids vials, ampoule injections and dry vial injections, dry syrups, ointments, inhalers, and Herbals. The company's product includes generic, antiviral, antidepressant, cough suppressant, electrolyte, histamine, estrogen, and much more. It generates maximum revenue through the Pharmaceutical drugs and formulations segment.

Syncom Formulation (India) (BOM:524470) Headlines

No Headlines